Cargando…
The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
The effects of enzalutamide monotherapy on prostate tumor downsizing and multiparametric MRI are currently unknown. Here we present the first case in literature of a patient with high-grade prostate cancer who underwent 3 months of neoadjuvant enzalutamide, for which the effects on mpMRI and histolo...
Autores principales: | Van der Roest, Rosanne CV., van Houdt, Petra J., Heijmink, Stijn WTPJ., de Jong, Jeroen, Bergman, André M., Zwart, Wilbert, van der Heide, Uulke A., van der Poel, Henk G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909636/ https://www.ncbi.nlm.nih.gov/pubmed/27335799 http://dx.doi.org/10.1016/j.eucr.2016.04.010 |
Ejemplares similares
-
Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018) -
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018) -
Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
por: Klawer, Edzo M.E., et al.
Publicado: (2018) -
Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer
por: Dinis Fernandes, Catarina, et al.
Publicado: (2023) -
Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)